MIGARD

This brand name is authorized in Estonia, Finland, Lithuania, United Kingdom

Active ingredients

The drug MIGARD contains one active pharmaceutical ingredient (API):

1 Frovatriptan
UNII D28J6W18HY - FROVATRIPTAN SUCCINATE

Frovatriptan is a selective agonist for 5-HT receptors. Frovatriptan is believed to act selectively on extracerebral, intracranial arteries to inhibit the excessive dilatation of these vessels in migraine.

Read about Frovatriptan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MIGARD Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CC07 Frovatriptan N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1161537, 1161548, 1161559, 1161560, 1161571, 1161582, 1161593
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 019808, 020027, 020053
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 43642
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1016988, 1016989, 1016990, 1016991, 1016992, 1016993

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.